AVEO Oncology Reports Full Year 2013 Financial Results And Outlines 2014 Strategic Plan

Published: Mar 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AVEO Oncology (NASDAQ: AVEO) today reported consolidated 2013 financial results and outlined its 2014 strategic plan and financial guidance.

“With the cost-containment measures implemented in the second half of 2013, AVEO ended the year in a strong financial position,” said Tuan Ha-Ngoc, president and chief executive officer of AVEO. “Our strategy going forward will focus on driving growth by investing in the continued advancement of our AV-380 program in cachexia and pursuing further development of our clinical-stage assets through collaborations.

Help employers find you! Check out all the jobs and post your resume.

Back to news